skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 3,022  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Transformation of NSCLC to SCLC after 1st- and 3rd-generation EGFR-TKI resistance and response to EP regimen and erlotinib: 2 CARE-compliant case reports
Material Type:
Article
Add to My Research

Transformation of NSCLC to SCLC after 1st- and 3rd-generation EGFR-TKI resistance and response to EP regimen and erlotinib: 2 CARE-compliant case reports

Medicine (Baltimore), 2021-03, Vol.100 (10), p.e25046-e25046 [Peer Reviewed Journal]

Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000025046 ;PMID: 33725888

Full text available

2
Correlation of iodine uptake and perfusion parameters between dual-energy CT imaging and first-pass dual-input perfusion CT in lung cancer
Material Type:
Article
Add to My Research

Correlation of iodine uptake and perfusion parameters between dual-energy CT imaging and first-pass dual-input perfusion CT in lung cancer

Medicine (Baltimore), 2017-07, Vol.96 (28), p.e7479-e7479 [Peer Reviewed Journal]

Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. 2017 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000007479 ;PMID: 28700488

Full text available

3
Muscle mass and association to quality of life in non‐small cell lung cancer patients
Material Type:
Article
Add to My Research

Muscle mass and association to quality of life in non‐small cell lung cancer patients

Journal of cachexia, sarcopenia and muscle, 2017-10, Vol.8 (5), p.759-767 [Peer Reviewed Journal]

2017 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders ;2017 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders. ;2017. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;ISSN: 2190-5991 ;ISSN: 2190-6009 ;EISSN: 2190-6009 ;DOI: 10.1002/jcsm.12206 ;PMID: 28493418

Full text available

4
The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors
Material Type:
Article
Add to My Research

The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors

Medicine (Baltimore), 2022-01, Vol.101 (3), p.e28617-e28617 [Peer Reviewed Journal]

Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. 2022 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000028617 ;PMID: 35060536

Full text available

5
C-terminal binding protein-2 is a prognostic marker for lung adenocarcinomas
Material Type:
Article
Add to My Research

C-terminal binding protein-2 is a prognostic marker for lung adenocarcinomas

Medicine (Baltimore), 2020-07, Vol.99 (31), p.e20076-e20076 [Peer Reviewed Journal]

Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. 2020 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000020076 ;PMID: 32756072

Full text available

6
Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma: Study protocol for case-control observational trial
Material Type:
Article
Add to My Research

Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma: Study protocol for case-control observational trial

Medicine (Baltimore), 2018-12, Vol.97 (50), p.e13676-e13676 [Peer Reviewed Journal]

Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. 2018 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000013676 ;PMID: 30558074

Full text available

7
Risk factors of postoperative acute lung injury following lobectomy for nonsmall cell lung cancer
Material Type:
Article
Add to My Research

Risk factors of postoperative acute lung injury following lobectomy for nonsmall cell lung cancer

Medicine (Baltimore), 2019-03, Vol.98 (13), p.e15078 [Peer Reviewed Journal]

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. 2019 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/md.0000000000015078 ;PMID: 30921242

Full text available

8
Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non‐small‐cell lung cancer
Material Type:
Article
Add to My Research

Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non‐small‐cell lung cancer

Journal of cachexia, sarcopenia and muscle, 2019-02, Vol.10 (1), p.73-83 [Peer Reviewed Journal]

2018 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders ;2018 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders. ;2019. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2190-5991 ;EISSN: 2190-6009 ;DOI: 10.1002/jcsm.12351 ;PMID: 30334618

Full text available

9
Dual-scale categorization based deep learning to evaluate programmed cell death ligand 1 expression in non-small cell lung cancer
Material Type:
Article
Add to My Research

Dual-scale categorization based deep learning to evaluate programmed cell death ligand 1 expression in non-small cell lung cancer

Medicine (Baltimore), 2021-05, Vol.100 (20), p.e25994-e25994 [Peer Reviewed Journal]

Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000025994 ;PMID: 34011092

Full text available

10
Expression and prognostic impact of CD49b in human lung cancer
Material Type:
Article
Add to My Research

Expression and prognostic impact of CD49b in human lung cancer

Medicine (Baltimore), 2022-02, Vol.101 (6), p.e28814-e28814 [Peer Reviewed Journal]

Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. 2022 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000028814 ;PMID: 35147120

Full text available

11
Association between pulmonary artery to aorta diameter ratio with pulmonary hypertension and outcomes in diffuse cystic lung diseases
Material Type:
Article
Add to My Research

Association between pulmonary artery to aorta diameter ratio with pulmonary hypertension and outcomes in diffuse cystic lung diseases

Medicine (Baltimore), 2021-06, Vol.100 (25), p.e26483-e26483 [Peer Reviewed Journal]

Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000026483 ;PMID: 34160461

Full text available

12
Small-cell lung cancer transformation from EGFR-mutant adenocarcinoma after EGFR-TKIs resistance: A case report
Material Type:
Article
Add to My Research

Small-cell lung cancer transformation from EGFR-mutant adenocarcinoma after EGFR-TKIs resistance: A case report

Medicine (Baltimore), 2021-08, Vol.100 (32), p.e26911-e26911 [Peer Reviewed Journal]

Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000026911 ;PMID: 34397927

Full text available

13
Effective treatment with icotinib in advanced lung adenocarcinoma harboring rare EGFR mutation G719A/L833V: A case report
Material Type:
Article
Add to My Research

Effective treatment with icotinib in advanced lung adenocarcinoma harboring rare EGFR mutation G719A/L833V: A case report

Medicine (Baltimore), 2022-08, Vol.101 (33), p.e30080-e30080 [Peer Reviewed Journal]

Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. 2022 ;ISSN: 1536-5964 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000030080 ;PMID: 35984165

Full text available

14
Prognostic significance of PD-L1 in advanced non-small cell lung carcinoma
Material Type:
Article
Add to My Research

Prognostic significance of PD-L1 in advanced non-small cell lung carcinoma

Medicine (Baltimore), 2020-11, Vol.99 (45), p.e23172 [Peer Reviewed Journal]

Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. 2020 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000023172 ;PMID: 33158004

Full text available

15
Lung carcinoma with diffuse cysts repeatedly misdiagnosed as pulmonary infections and lymphoid interstitial pneumonia: A case report
Material Type:
Article
Add to My Research

Lung carcinoma with diffuse cysts repeatedly misdiagnosed as pulmonary infections and lymphoid interstitial pneumonia: A case report

Medicine (Baltimore), 2024-02, Vol.103 (5), p.e37002-e37002 [Peer Reviewed Journal]

Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc. 2024 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000037002 ;PMID: 38306516

Full text available

16
Mesenchymal cystic hamartoma of the lung: A case report
Material Type:
Article
Add to My Research

Mesenchymal cystic hamartoma of the lung: A case report

Medicine (Baltimore), 2022-01, Vol.101 (1), p.e28242-e28242 [Peer Reviewed Journal]

Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. 2022 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000028242 ;PMID: 35029876

Full text available

17
Concomitant lung adenocarcinoma and pulmonary cryptococcosis confirmed by pathologic examinations
Material Type:
Article
Add to My Research

Concomitant lung adenocarcinoma and pulmonary cryptococcosis confirmed by pathologic examinations

Medicine (Baltimore), 2019-12, Vol.98 (50), p.e18316-e18316 [Peer Reviewed Journal]

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. 2019 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000018316 ;PMID: 31852116

Full text available

18
Lung adenocarcinoma harboring complex EML4-ALK fusion and BRAF V600E co-mutation responded to alectinib
Material Type:
Article
Add to My Research

Lung adenocarcinoma harboring complex EML4-ALK fusion and BRAF V600E co-mutation responded to alectinib

Medicine (Baltimore), 2022-10, Vol.101 (40), p.e30913-e30913 [Peer Reviewed Journal]

Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. 2022 ;ISSN: 1536-5964 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000030913 ;PMID: 36221356

Full text available

19
Systemic immune-inflammation index is a promising noninvasive marker to predict survival of lung cancer: A meta-analysis
Material Type:
Article
Add to My Research

Systemic immune-inflammation index is a promising noninvasive marker to predict survival of lung cancer: A meta-analysis

Medicine (Baltimore), 2019-01, Vol.98 (3), p.e13788-e13788 [Peer Reviewed Journal]

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. 2019 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000013788 ;PMID: 30653090

Full text available

20
C-reactive protein is a significant predictor of improved survival in patients with advanced non-small cell lung cancer
Material Type:
Article
Add to My Research

C-reactive protein is a significant predictor of improved survival in patients with advanced non-small cell lung cancer

Medicine (Baltimore), 2019-06, Vol.98 (26), p.e16238-e16238 [Peer Reviewed Journal]

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. 2019 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000016238 ;PMID: 31261584

Full text available

Results 1 - 20 of 3,022  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (2,994)

Refine My Results

New Records 

  1. New From Last 3 Month  (26)
  2. More options open sub menu

Language 

  1. Japanese  (126)
  2. Norwegian  (1)
  3. More options open sub menu

Searching Remote Databases, Please Wait